|
|
 |
|
Viewing report
|
|
|
|
Allergies and Allergy Remedies in the United States 2009
Mintel, Feb 2009, Pages: 96
The U.S. OTC allergy remedy market is driven by a range of factors, preeminently the incidence of allergies, which afflict an estimated 50 million sufferers, according to the American Academy of Asthma Allergy & Immunology. The most important internal driver for sales of these products is the Rx-to-OTC switch of allergy remedies, which have infused the market with substantial revenue and aided growth between 2003 and 2008. Mintel’s report provides an in-depth analysis of these drivers, as well as a complete examination of the following features of the market:
- The role of the child and elderly populations, which are specifically susceptible to allergies, and are forecast to increase in number in the coming years
- The self-diagnosis/self-medication movement in the U.S., which brings more consumers to the OTC aisle
- Growth of the allergy remedy market within the larger cold/allergy/sinus remedy market
- How the impact of Rx switches has allowed a select handful of companies to dominate sales
- Marketing of brand qualities and the attempt to position remedies as time-saving, clarity-providing and life-enhancing
Customers who bought this item also bought
Cold Flu and Allergy Remedies in the United States
Cough, Cold and Allergy (Hay Fever) Remedies in France
Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland
Cough, Cold and Sore Throat Remedies - US - 2009
Cough, Cold and Allergy (hay Fever) Remedies in South Korea
The 2009-2014 Outlook for Cough, Cold, and Allergy Remedies in Japan
Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
Cough, Cold and Allergy (hay Fever) Remedies in New Zealand
Cough, Cold and Allergy (Hay Fever) Remedies in Vietnam
Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
Cough, Cold and Allergy (hay Fever) Remedies in Thailand
Cough, Cold and Allergy (hay Fever) Remedies in South Africa
|
|
|
|
